
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.71 | 3.71 | 0.00 |
Shares | 96.29 | 96.29 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.06 | 21.76 |
Price to Book | 2.79 | 3.09 |
Price to Sales | 2.11 | 2.10 |
Price to Cash Flow | 14.11 | 12.21 |
Dividend Yield | 0.50 | 0.65 |
5 Years Earnings Growth | 11.15 | 14.25 |
Name | Net % | Category Average |
---|---|---|
Technology | 38.91 | 23.83 |
Healthcare | 21.05 | 20.43 |
Industrials | 18.51 | 20.18 |
Consumer Cyclical | 9.21 | 11.16 |
Financial Services | 6.02 | 10.09 |
Consumer Defensive | 5.29 | 4.57 |
Real Estate | 1.00 | 2.97 |
Number of long holdings: 68
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Prestige Consumer Health | US74112D1019 | 2.87 | 85.06 | +0.52% | |
RB Global | CA74935Q1072 | 2.47 | 105.13 | -0.12% | |
Q2 Holdings | US74736L1098 | 2.41 | 91.27 | +1.43% | |
ExlServices | US3020811044 | 2.38 | 47.99 | +2.02% | |
Descartes Systems | CA2499061083 | 2.25 | 140.10 | +0.83% | |
Dorman | US2582781009 | 2.25 | 126.67 | -0.27% | |
Cohen Steers | US19247A1007 | 2.23 | 76.33 | +1.64% | |
Globus Medical | US3795772082 | 2.10 | 59.92 | +0.62% | |
Cyberark Software | IL0011334468 | 1.98 | 403.76 | +2.95% | |
AptarGroup | US0383361039 | 1.97 | 153.31 | +0.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nicholas | 4.13B | -3.94 | 13.09 | 10.26 | ||
Nicholas II I | 978.79M | -4.81 | 5.21 | 8.54 | ||
Nicholas Equity Income I | 440.54M | -2.68 | 5.04 | 7.92 | ||
Nicholas II N | 73M | 6.45 | 1.33 | 9.34 | ||
Nicholas Limited Edition N | 17.18M | 11.58 | -0.25 | 9.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review